APLS
Apellis Pharmaceuticals Inc.
$24.50
-$0.62(-2.47%)
51
Overall
40
Value
63
Tech
50
Quality
Market Cap
$3.18B
Volume
904.53K
52W Range
$16.10 - $35.72
Target Price
$37.44
EPS Estimates Overview
| Current Quarter | $0.64 | Next Quarter | $-0.38 |
| Current Year | $-0.66 | Next Year | $-1.05 |
| QoQ Growth | -159.4% | YoY Growth | -59.1% |
| 3Y EPS CAGR | +43.4% | Target Price | $37.44 |
| Consensus | Buy | Upside | +52.8% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | APLS | $24.50 | -2.5% | 904.53K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Apellis Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW